NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
10/17/2023
Back to search
Official data from USPTO
CIGNA PATHWELL BONE & JOINT
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
CIGNA PATHWELL BONE & JOINT
ST13
US500000097414087Class
35, 36, 44
Filing
97414087
Registration
7197678
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
22
Latest update
10/17/2023
Trademark type
Word
Nice classes
35, 36, 44
Filing date
05/17/2022
Registration date
10/17/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/17/2023
Last transaction
10/17/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
09/28/2022
First use in commerce
10/25/2022
Drawing code
4
Owner type
03
Owner location
Wilmington, DE, US
Examiner
AREY, BRANDON LEON
Law office
N90
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Cigna Intellectual Property, Inc.
Representatives
Cigna Intellectual Property, Inc.
Technical classification
Nice Classes
Class 35Class 36Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Cost management for the healthcare benefit and prescription drug benefit plans of individuals with musculoskeletal conditions; business servicespharmaceutical cost management services and drug utilization review services for the prescription drug and medical formulary plans of others with musculoskeletal conditions; consulting services regarding healthcare costs management and retail pharmacy services for those with musculoskeletal conditions; Drug utilization review services and drug and medical formulary cost management services for those with musculoskeletal conditions; pharmaceutical and medical cost management services and drug utilization review services for those musculoskeletal conditions; in-network provider advisory services and consultancy servicesstrategic business analysis and business advice in the field of medical insurance regarding pharmacy benefit managementmedical benefit management; business data analysis regarding health care benefit plan pharmaceutical end-user behaviorhealth care benefit plan healthcare use behavior in the field of musculoskeletal conditions; market study and analysis of healthcarehealthcare benefitspharmacy benefits effecting health behavior change and choice at the patient level for musculoskeletal conditions; providing business intelligence services in the field of pharmacy benefit management; administration of employee benefit plans concerning pharmacy benefit plans for musculoskeletal patients; cost management for pharmacy health care benefit servicestrackingmonitoringassessing and analyzing information and statistics regarding patient prescription drug use and healthcare habitsproviding a predictive model to determine musculoskeletal patients' future prescription drug and healthcare habits to identify potential cost savings for those with musculoskeletal conditions
Class 36
Pharmacy benefit management services; pharmacy benefit management consulting services for those with musculoskeletal conditions; medical benefit management services concerning insurance for those with musculoskeletal conditions; advisory services and consultancy regarding medical insurance healthcare benefitsin-network coveragepharmacy benefits; provision of information and analysis in the fields of healthcare insurance plan benefits and pharmacy benefits for those with musculoskeletal conditions; prescription health care benefit coverage plans servicesproviding insurance underwriting and claims administration of prescription drug plans for qualified beneficiaries with musculoskeletal conditions; administration of pharmacy benefit plans concerning insurance; pharmacy benefit management services concerning insurancetrackingmonitoringassessing and analyzing information and statistics regarding patient prescription drug use and healthcare habitsproviding a predictive model to determine musculoskeletal patients' future prescription drug and healthcare habitsall to identify clinical benefits for those with musculoskeletal conditions; prescription drug healthcare benefit plan servicesproviding information to patients regarding in-network services in the field of complex musculoskeletal case management programs
Class 44
Advisory services and consultancy regarding musculoskeletal healthcare; healthcare serviceswellness and disease management programs for musculoskeletal patients; health care servicesmusculoskeletal disease management programs and complex musculoskeletal case management services in the nature of providing health consultation services to patients regarding medication compliance and providing healthcare and medical information regarding health and safety issues; providing medical information and analysis in the fields of musculoskeletal healthcarepharmaceuticals; providing information in the field of musculoskeletal healthcare to pharmacy benefit management clientsconsultants and brokers
Publications
History of USPTO decisions and trademark events.
22 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
10/17/2023
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
09/09/2023
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
09/08/2023
SUPC
STATEMENT OF USE PROCESSING COMPLETE
09/07/2023
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
09/07/2023
IUAF
USE AMENDMENT FILED
08/28/2023
EISU
TEAS STATEMENT OF USE RECEIVED
08/28/2023
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
02/28/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/03/2023
PUBO
PUBLISHED FOR OPPOSITION
01/03/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/14/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/23/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/21/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/21/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/21/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
07/05/2022
GNRT
NON-FINAL ACTION E-MAILED
07/05/2022
CNRT
NON-FINAL ACTION WRITTEN
07/05/2022
DOCK
ASSIGNED TO EXAMINER
06/23/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/23/2022
NWAP
NEW APPLICATION ENTERED
05/20/2022
Continuous trademark protection
Get notified about every new filing that threatens CIGNA PATHWELL BONE & JOINT or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.